HNGE — Hinge Health, Inc.

Hinge Health Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Q4 Revenue: $171 million, up 46% year-over-year.
• Full Year Revenue: $588 million, a 51% increase from 2024.
• Last Twelve Months (LTM) Calculated Billings: $671 million, up 44% year-over-year.
• Gross Margin: 85% in Q4, 83% for the full year.
• Operating Margin: 28% in Q4, 20% for the full year.
• Free Cash Flow: $62 million in Q4, $180 million for the full year, with a free cash flow margin of 31%.
• Rule of 40 Metric: 81 for the full year, 82 in Q4.
• Client Base: Approximately 24.6 million contracted lives across over 2,800 clients, representing 25% year-over-year growth.

2. Strategic Updates and Business Highlights

• AI Initiatives: Significant advancements in AI-driven tools improved care delivery efficiency, allowing a 47% increase in member service without raising care team costs.
• Hinge Select: Launched a high-performance provider network, currently available to several hundred thousand lives, with early success in reducing unnecessary surgeries.
• Sales Performance: Exceptional sales season with 4.8 million net new contracted lives added, including significant growth in the non-self-insured segment.
• Member Engagement: Achieved high member satisfaction with NPS scores at an all-time high, and positive early feedback on AI care assistant Robin.

3. Forward Guidance and Outlook

• Q1 2026 Revenue Guidance: Expected to be between $171 million to $173 million, representing 39% year-over-year growth.
• Full Year 2026 Revenue Guidance: Projected to be in the range of $732 million to $742 million, indicating 25% year-over-year growth.
• Operating Profit Guidance: Non-GAAP income from operations expected to be $151 million to $156 million for 2026, with a margin of 21%.

4. Bad News, Challenges, or Points of Concern

• Yield Expectations: Yield is expected to remain flat in 2026, which could limit revenue growth potential.
• Hinge Select Revenue Impact: Minimal revenue contribution anticipated from Hinge Select until 2027, despite its strategic importance.
• Competitive Pressures: Concerns about potential competition from larger tech companies and the need to maintain a competitive edge through proprietary data and clinical validation.

5. Notable Q&A Insights

• Competitive Moats: CEO Daniel Perez emphasized Hinge Health's unique advantages, including proprietary data from over 100 million treatment sessions and established distribution channels.
• Engagement-Based Pricing Model: Transitioning to this model has led to improved member engagement, although ASPs are expected to remain flat in 2026.
• TAM Expansion: Discussions around expanding into the Medicare population and the potential of the upcoming CMS access program, though significant contributions are not expected until 2027.
• M&A Strategy: Focus on organic growth with interest in smaller acquisitions that align with their vision of automating healthcare delivery.

Overall, Hinge Health showcased strong financial performance and strategic initiatives while acknowledging challenges related to yield and competitive pressures. The outlook for 2026 remains positive, with expectations for continued growth and innovation.